open access

Vol 5, No 1 (2002)
Published online: 2002-01-17
Submitted: 2012-01-23
Get Citation

The effects of radioiodine therapy on peripheral blood lymphocyte subpopulations in patients with Graves? disease. Preliminary report

Magdalena D. Turowska, Dariusz Turowski, Jolanta Wysocka, Franciszek Rogowski
Nucl. Med. Rev 2002;5(1):35-38.

open access

Vol 5, No 1 (2002)
Published online: 2002-01-17
Submitted: 2012-01-23

Abstract

BACKGROUND: Treatment of Graves’ disease patients with radioactive iodide (131I) is becoming the standard therapy in an increasing group of cases but can induce alterations in immune response, like increasing levels of thyroid autoantibodies, and, in part, exacerbation of ophthalmopathy.
The aim of this study was to assess the changes in peripheral blood (PB) lymphocyte subpopulations after 131I treatment of patients with Graves’ disease.
MATERIAL AND METHODS: The study was carried out in a group of 30 patients with Graves’ disease (23 f; 7 m) 49.5 ± 10.0 years of age, 26 with different subjective ocular signs like gritty sensation, increased lacrimation, orbital pain, and exophthalmos. PB lymphocyte subsets were analysed by cytofluorometry, serum concentration of TSH and fT4 were evaluated before and 6 weeks after radioiodine treatment.
RESULTS: After 131I treatment a significant increase in CD3+, CD4+, CD3+HLA-DR+ and a decrease in CD19+ percentages of lymphocyte subsets were found in comparison with the initial evaluation. No significant changes in percentage of CD8+ and NK (CD3–CD16+ CD56+) cells were observed during this study. A significant increase in TSH and a slight decrease in fT4 concentration concentration took place in the 6th week after 131I application. The patients without subjective improvement of ocular signs during the therapy initially had a percentage of CD3+, CD8+ lymphocytes which was significantly lower compared with those with regression of ocular signs observed after 131I treatment.
CONCLUSIONS: The changes in PB lymphocyte subsets caused by 131I treatment of Graves’ disease confirm the involvement of acquired cellular immunity after radiation damage of the thyroid gland. The decreased initial percentage of CD8+ and CD3+ lymphocytes could help make a prediction of ocular symptoms persisting after radioiodine treatment in some patients with ophthalmopathy.

Abstract

BACKGROUND: Treatment of Graves’ disease patients with radioactive iodide (131I) is becoming the standard therapy in an increasing group of cases but can induce alterations in immune response, like increasing levels of thyroid autoantibodies, and, in part, exacerbation of ophthalmopathy.
The aim of this study was to assess the changes in peripheral blood (PB) lymphocyte subpopulations after 131I treatment of patients with Graves’ disease.
MATERIAL AND METHODS: The study was carried out in a group of 30 patients with Graves’ disease (23 f; 7 m) 49.5 ± 10.0 years of age, 26 with different subjective ocular signs like gritty sensation, increased lacrimation, orbital pain, and exophthalmos. PB lymphocyte subsets were analysed by cytofluorometry, serum concentration of TSH and fT4 were evaluated before and 6 weeks after radioiodine treatment.
RESULTS: After 131I treatment a significant increase in CD3+, CD4+, CD3+HLA-DR+ and a decrease in CD19+ percentages of lymphocyte subsets were found in comparison with the initial evaluation. No significant changes in percentage of CD8+ and NK (CD3–CD16+ CD56+) cells were observed during this study. A significant increase in TSH and a slight decrease in fT4 concentration concentration took place in the 6th week after 131I application. The patients without subjective improvement of ocular signs during the therapy initially had a percentage of CD3+, CD8+ lymphocytes which was significantly lower compared with those with regression of ocular signs observed after 131I treatment.
CONCLUSIONS: The changes in PB lymphocyte subsets caused by 131I treatment of Graves’ disease confirm the involvement of acquired cellular immunity after radiation damage of the thyroid gland. The decreased initial percentage of CD8+ and CD3+ lymphocytes could help make a prediction of ocular symptoms persisting after radioiodine treatment in some patients with ophthalmopathy.
Get Citation

Keywords

131I; lymphocytes; Graves? disease

About this article
Title

The effects of radioiodine therapy on peripheral blood lymphocyte subpopulations in patients with Graves? disease. Preliminary report

Journal

Nuclear Medicine Review

Issue

Vol 5, No 1 (2002)

Pages

35-38

Published online

2002-01-17

Bibliographic record

Nucl. Med. Rev 2002;5(1):35-38.

Keywords

131I
lymphocytes
Graves? disease

Authors

Magdalena D. Turowska
Dariusz Turowski
Jolanta Wysocka
Franciszek Rogowski

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl